Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline on Balance in Parkinson's Disease
NCT07077187Phase 4Withdrawn
- Sponsor
- New York Medical College
- Start
- Sep 2014
- Primary completion
- Jul 2017
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by New York Medical College. Planned start Sep 2014; status: withdrawn.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07077187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07077187.